Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Orphanet Journal of Rare Diseases|April 11, 2023
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspectiveMercedeh Ghadessi, Junrui Di, Chenkun Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2020
Combining Three-Dimensional Modeling with Artificial Intelligence to Increase Specificity and Precision in Peptide-MHC Binding PredictionsMichelle P Aranha, Yead S M Jewel, Robert A Beckman, et al.
Orphanet Journal of Rare Diseases|March 14, 2020
A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)Mercedeh Ghadessi, Rui Tang, Joey Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerMartin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Molecular and Cellular Biology|September 6, 2007
Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesisRanga N Venkatesan, Piper M Treuting, Evan D Fuller, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2016
Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissuesJeffrey D Krimmel, Michael W Schmitt, Maria I Harrell, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Endocrinology|October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Translational Oncology|August 3, 2013
Altered RECQ Helicase Expression in Sporadic Primary Colorectal CancersVictoria Valinluck Lao, Piri Welcsh, Yanxin Luo, et al.
Oncotarget|November 27, 2016
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatmentShruti Rao, Robert A Beckman, Shahla Riazi, et al.
Pageof 18